20
Chongqing Carelife Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is CLINDAMYCIN PHOSPHATE USP, with a corresponding US DMF Number 16357.
Remarkably, this DMF maintains an Active status since its submission on January 23, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of August 17, 2013, and payment made on August 07, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II